Offer An Article

Pandemic Latest News

Stents

Stents given to patients when unnecessary?

New technologies have shown that in around thirty percent of patients cardiac stents are entirely unnecessary, according to cardiologist Dr Ramesh Babu Pothineni, the managing director of Ramesh Hospitals Group. Cardiac stents have been a matter of contention in recent years in India, primarily due to them being the focal point over the capping of …

Stents given to patients when unnecessary? Read More »

Drug producers to be required to display manufacturing cost

In a move that is already causing distress amongst pharmaceutical companies, India’s Health Ministry is putting in motion requirements for all drugs to display the manufacturing costs on the label. This would bring not only the costs of manufacture, but the assumed profit margins of the medication into the public domain. The Central Drugs Standard …

Drug producers to be required to display manufacturing cost Read More »

US intervention in price capping

The US seems intent on stopping  the Modi administration extending price caps on medical device. The US has outright requested the Indian government to not extend the caps said a US trade official in discussions with Reuters. There has also been a request that, should companies based in the US no longer wish to provide …

US intervention in price capping Read More »

Abbott Healthcare to withdraw cardiac stents from India

The Indian government’s decision to cap the price mark ups imposed on cardiac stents was feared by some for its potential to cause foreign companies to simply stop marketing their stents in India. These fears appear to have come to fruition as Abbott Healthcare have recently sent requests to the National Pharmaceutical Pricing Authority (NPPA) …

Abbott Healthcare to withdraw cardiac stents from India Read More »

Price cap on stents, how hospitals and manufacturers may beat the cap

Hospitals and manufacturers are now faced with a reduction in profits margin of up to 85 percent following the price capping of cardiac stents. The price cap has had some unintended consequences. Amongst these are the myriad of ways both hospitals and manufacturers have tried to avoid the losses imposed on them by the cuts. …

Price cap on stents, how hospitals and manufacturers may beat the cap Read More »

Held hostage by potential heart attacks, the disparities in the cost of stents

Heart conditions are on the rise in India. Over the last few decades, lifestyles have changed and become more sedentary as a result of industrialisation and the rapid growth of the IT industry. Consequently, surgeries such as angioplasties – which involves the widening of an artery or vein to clear blockages using coronary stents – …

Held hostage by potential heart attacks, the disparities in the cost of stents Read More »

India breaking into the market for stent development

India may be considered the pharmacy of the world in terms of drug production, but it imports nearly 80% of its medical devices. Barriers to entry being typically lower than other countries and this makes  India a huge market for foreign product sales. Now,  there are  calls for India to begin creating home grown products. …

India breaking into the market for stent development Read More »